MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/720/0.01/20.12.24 Stock

Warrant

DE000MB33S38

Real-time Bid/Ask 12:25:32 2024-06-03 EDT
0.067 EUR / 0.094 EUR +22.73% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/720/0.01/20.12.24
1 month-31.96%
3 months-74.62%
Date Price Change
24-06-03 0.068 +3.03%
24-05-31 0.066 -4.35%
24-05-30 0.069 -6.76%
24-05-29 0.074 -3.90%
24-05-28 0.077 +14.93%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 09:33 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MB33S3
ISINDE000MB33S38
Date issued 2023-02-01
Strike 720 $
Maturity 2024-12-20 (200 Days)
Parity 100 : 1
Emission price 0.37
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.55
Lowest since issue 0.059
Delta0.14x
Omega 7.830
Premium48.37x
Gearing57.44x
Moneyness 0.6820
Difference Strike 230.7 $
Difference Strike %+32.04%
Spread 0.023
Spread %25.56%
Theoretical value 0.0795
Implied Volatility 38.57 %
Total Loss Probability 91.60 %
Intrinsic value 0.000000
Present value 0.0795
Break even 728.65 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
497 USD
Average target price
563.8 USD
Spread / Average Target
+13.45%
Consensus